Completed PHASE4 INTERVENTIONAL 2-arm NCT00299091

Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients

Open, Parallel and Randomised Pilot Clinical Trial to Evaluate the Utility of the Therapeutic Monitoring of Plasma Levels of Efavirenz in Hiv-Infected Patients Initiating an Antiretroviral Treatment Regimen With Sustiva

Sponsor: Germans Trias i Pujol Hospital

Conditions HIV

Interventions Efavirenz capsules 200 mg and 600 mg

Updated 6 times since 2017 Last updated: Feb 13, 2018 Started: Sep 30, 2006 Primary completion: Oct 31, 2008 Completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates HIV and is currently completed. Germans Trias i Pujol Hospital leads this study, which shows 6 recorded versions since 2006 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Mar 2018 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Mar 2018 [monthly]

Completed PHASE4

First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Germans Trias i Pujol Hospital

Data source: Germans Trias i Pujol Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Badalona, Spain